Mostrar 1 - 6 resultats de 6 per cerca 'Simran Dhariwal (15053663)', hora de la petició: 0.01sec Refinar resultats
  1. 1
    Figure S6 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models

    Figure S6 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models per Elizabeth R. Tucker (15053624)

    Publicat 2025
    Altres autors:
    Afegir a favorits
    Guardat en:
  2. 2
    Figure S2 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models

    Figure S2 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models per Elizabeth R. Tucker (15053624)

    Publicat 2025
    Altres autors:
    Afegir a favorits
    Guardat en:
  3. 3
    Figure S5 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models

    Figure S5 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models per Elizabeth R. Tucker (15053624)

    Publicat 2025
    Altres autors:
    Afegir a favorits
    Guardat en:
  4. 4
    Figure S1 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models

    Figure S1 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models per Elizabeth R. Tucker (15053624)

    Publicat 2025
    Altres autors:
    Afegir a favorits
    Guardat en:
  5. 5
    Figure S4 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models

    Figure S4 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models per Elizabeth R. Tucker (15053624)

    Publicat 2025
    Altres autors:
    Afegir a favorits
    Guardat en:
  6. 6
    Figure S3 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models

    Figure S3 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models per Elizabeth R. Tucker (15053624)

    Publicat 2025
    Altres autors:
    Afegir a favorits
    Guardat en:

Eines de cerca: